Study of BW-50218 in Healthy Participants

Recruiting Phase 1 Interventional Study
Healthy Participants Study
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Shanghai Argo Biopharmaceutical Co., Ltd. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Phase 1, Single Ascending Dose Study of Subcutaneous BW-50218 in Healthy Participants

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Capable of providing written informed consent and complying with all study procedures for the duration of the study. * Body weight and body mass index (BMI) within a range considered appropriate for study participation by the investigator. * Female participants must be non-pre…
Contacts

Zhi Hua

+86 185 1618 7545

zhi.hua@argobiopharma.com

CONTACT